Restatement of Previously Issued Unaudited Condensed Financial Statements for the Nine Months Ended November 30, 2021 (Details) - Schedule of the company’s previously issued statement of shareholder deficit - USD ($)	Nov. 30, 2021	Feb. 28, 2021
As Previously Reported [Member]
Restatement of Previously Issued Unaudited Condensed Financial Statements for the Nine Months Ended November 30, 2021 (Details) - Schedule of the company’s previously issued statement of shareholder deficit [Line Items]
Balance	$ (20,291,421)	$ (19,749,750)
As Previously Reported [Member] | Common Stock [Member]
Restatement of Previously Issued Unaudited Condensed Financial Statements for the Nine Months Ended November 30, 2021 (Details) - Schedule of the company’s previously issued statement of shareholder deficit [Line Items]
Balance	$ 8,054	$ 7,111
Balance (in Shares)	80,539,202	71,107,442
As Previously Reported [Member] | Additional Paid-In Capital [Member]
Restatement of Previously Issued Unaudited Condensed Financial Statements for the Nine Months Ended November 30, 2021 (Details) - Schedule of the company’s previously issued statement of shareholder deficit [Line Items]
Balance	$ 448,953,216	$ 446,126,638
As Previously Reported [Member] | Accumulated Deficit [Member]
Restatement of Previously Issued Unaudited Condensed Financial Statements for the Nine Months Ended November 30, 2021 (Details) - Schedule of the company’s previously issued statement of shareholder deficit [Line Items]
Balance	(469,252,691)	(465,883,499)
Prior period revisions [Member]
Restatement of Previously Issued Unaudited Condensed Financial Statements for the Nine Months Ended November 30, 2021 (Details) - Schedule of the company’s previously issued statement of shareholder deficit [Line Items]
Prior period revisions	(1,366,375)	(1,366,375)
Prior period revisions [Member] | Common Stock [Member]
Restatement of Previously Issued Unaudited Condensed Financial Statements for the Nine Months Ended November 30, 2021 (Details) - Schedule of the company’s previously issued statement of shareholder deficit [Line Items]
Prior period revisions	$ (2)	$ (2)
Prior period revisions (in Shares)
Prior period revisions [Member] | Additional Paid-In Capital [Member]
Restatement of Previously Issued Unaudited Condensed Financial Statements for the Nine Months Ended November 30, 2021 (Details) - Schedule of the company’s previously issued statement of shareholder deficit [Line Items]
Prior period revisions	$ 122,634	$ 122,634
Prior period revisions [Member] | Accumulated Deficit [Member]
Restatement of Previously Issued Unaudited Condensed Financial Statements for the Nine Months Ended November 30, 2021 (Details) - Schedule of the company’s previously issued statement of shareholder deficit [Line Items]
Prior period revisions	(1,489,007)	(1,489,007)
Corrections of errors [Member]
Restatement of Previously Issued Unaudited Condensed Financial Statements for the Nine Months Ended November 30, 2021 (Details) - Schedule of the company’s previously issued statement of shareholder deficit [Line Items]
Corrections of errors
Corrections of errors [Member] | Common Stock [Member]
Restatement of Previously Issued Unaudited Condensed Financial Statements for the Nine Months Ended November 30, 2021 (Details) - Schedule of the company’s previously issued statement of shareholder deficit [Line Items]
Corrections of errors
Corrections of errors (in Shares)	(4,433)	(4,433)
Corrections of errors [Member] | Additional Paid-In Capital [Member]
Restatement of Previously Issued Unaudited Condensed Financial Statements for the Nine Months Ended November 30, 2021 (Details) - Schedule of the company’s previously issued statement of shareholder deficit [Line Items]
Corrections of errors
Corrections of errors [Member] | Accumulated Deficit [Member]
Restatement of Previously Issued Unaudited Condensed Financial Statements for the Nine Months Ended November 30, 2021 (Details) - Schedule of the company’s previously issued statement of shareholder deficit [Line Items]
Corrections of errors
As Restated [Member]
Restatement of Previously Issued Unaudited Condensed Financial Statements for the Nine Months Ended November 30, 2021 (Details) - Schedule of the company’s previously issued statement of shareholder deficit [Line Items]
Balance	(21,931,236)	$ (21,116,125)
As Restated [Member] | Common Stock [Member]
Restatement of Previously Issued Unaudited Condensed Financial Statements for the Nine Months Ended November 30, 2021 (Details) - Schedule of the company’s previously issued statement of shareholder deficit [Line Items]
Balance	$ 8,052	$ 7,109
Balance (in Shares)	80,534,769	71,103,009
As Restated [Member] | Additional Paid-In Capital [Member]
Restatement of Previously Issued Unaudited Condensed Financial Statements for the Nine Months Ended November 30, 2021 (Details) - Schedule of the company’s previously issued statement of shareholder deficit [Line Items]
Balance	$ 449,229,238	$ 446,249,272
As Restated [Member] | Accumulated Deficit [Member]
Restatement of Previously Issued Unaudited Condensed Financial Statements for the Nine Months Ended November 30, 2021 (Details) - Schedule of the company’s previously issued statement of shareholder deficit [Line Items]
Balance	(471,168,526)	$ (467,372,506)
Share-based compensation addition [Member]
Restatement of Previously Issued Unaudited Condensed Financial Statements for the Nine Months Ended November 30, 2021 (Details) - Schedule of the company’s previously issued statement of shareholder deficit [Line Items]
Share-based compensation addition	153,388
Share-based compensation addition [Member] | Common Stock [Member]
Restatement of Previously Issued Unaudited Condensed Financial Statements for the Nine Months Ended November 30, 2021 (Details) - Schedule of the company’s previously issued statement of shareholder deficit [Line Items]
Share-based compensation addition
Share-based compensation addition [Member] | Additional Paid-In Capital [Member]
Restatement of Previously Issued Unaudited Condensed Financial Statements for the Nine Months Ended November 30, 2021 (Details) - Schedule of the company’s previously issued statement of shareholder deficit [Line Items]
Share-based compensation addition	153,388
Share-based compensation addition [Member] | Accumulated Deficit [Member]
Restatement of Previously Issued Unaudited Condensed Financial Statements for the Nine Months Ended November 30, 2021 (Details) - Schedule of the company’s previously issued statement of shareholder deficit [Line Items]
Share-based compensation addition
Net loss reduction [Member]
Restatement of Previously Issued Unaudited Condensed Financial Statements for the Nine Months Ended November 30, 2021 (Details) - Schedule of the company’s previously issued statement of shareholder deficit [Line Items]
Net loss reduction	(426,828)
Net loss reduction [Member] | Common Stock [Member]
Restatement of Previously Issued Unaudited Condensed Financial Statements for the Nine Months Ended November 30, 2021 (Details) - Schedule of the company’s previously issued statement of shareholder deficit [Line Items]
Net loss reduction
Net loss reduction [Member] | Additional Paid-In Capital [Member]
Restatement of Previously Issued Unaudited Condensed Financial Statements for the Nine Months Ended November 30, 2021 (Details) - Schedule of the company’s previously issued statement of shareholder deficit [Line Items]
Net loss reduction
Net loss reduction [Member] | Accumulated Deficit [Member]
Restatement of Previously Issued Unaudited Condensed Financial Statements for the Nine Months Ended November 30, 2021 (Details) - Schedule of the company’s previously issued statement of shareholder deficit [Line Items]
Net loss reduction	$ (426,828)